Almirall, a global pharmaceutical company member of CataloniaBio & HealthTech, launches its fifth call AlmirallShare to establish collaborations in research and identify new treatments for skin health.

The call seeks partnering opportunities for new assets (chemical entities, biologics and other advanced therapies) in order to maximize their value as innovative therapies.

Scientists all over the world can submit their proposal until 31 October, 2020.

AlmirallShare, led by Maribel Crespo, is responsible for 50% of the private-public collaborations at Almirall. This open innovation platform has received more than 350 proposals since its launch in 2017.

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream